Allan CM, Taylor S, Taylor JM (1997) Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster. J. Biol. Chem. 272:29113–29119.
Arai H, Monteclaro FS, Tsou C-L, Franci C, Charo IF (1997) Dissociation of chemotaxis from agonist-induced receptor internalization in a lymphocyte cell line transfected with CCR2B. Evidence that directed migration does not require rapid modulation of signaling at the receptor level. J. Biol. Chem. 272:25037–25042.
Arai H, Tsou C-L, Charo IF (1997) Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: Evidence that directed migration is mediated by βγ dimers released by activation of Gα1-coupled receptors. Proc. Natl. Acad. Sci. USA 94:14495–14499.
Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C–C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552–2561.
Burstein ES, Bräuner-Osborne H, Spalding TA, Conklin BR, Brann MR (1997) Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: Transduction of proliferative signals. J. Neurochem. 68:525–533.
Creighton WM, Taylor AJ, Dichek DA, Dong G, Roberts AB, Schulick AH, Mannam P, Virmani R (1997) Regional variability in the time course of TGF-b1 expression, cellular proliferation and extracellular matrix expansion following arterial injury. Growth Factors 14:297–306.
Dichek DA (1997) Control of thrombosis on synthetic graft surfaces—gene transfer approach. J. Vasc. Surg. 25:1107–1108.
Duell T, Nielsen LB, Jones A, Young SG, Weier H-UG (1997) Construction of two near-kilobase resolution restriction maps of the 5′ regulatory region of the human apolipoprotein B gene by quantitative DNA fiber mapping (QDFM). Cytogenet. Cell. Genet. 79:64–70.
Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou C-L, Goldsmith MA, Charo IF (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94:5061–5066.
Grunfeld C, Doerrler W, Pang M, Jensen P, Weisgraber KH, Feingold KR (1997) Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 82:3734–3740.
Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD (1997) Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J. Neurosci. 17:6114–6121.
Herz J, Willnow TE, Farese RV Jr (1997) Cholesterol, hedgehog and embryogenesis. Nat. Genet. 15:123–124.
Huang Y, Rall SC Jr, Mahley RW (1997) Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler. Thromb. Vasc. Biol. 17:2817–2824.
Huang Y, Schwendner SW, Rall SC Jr, Sanan DA, Mahley RW (1997) Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J. Biol. Chem. 272:22685–22694.
Hussain MM, Goldberg IJ, Weisgraber KH, Mahley RW, Innerarity TL (1997) Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity. Arterioscler. Thromb. Vasc. Biol. 17:1407–1413.
Ji Z-S, Dichek HL, Miranda RD, Mahley RW (1997) Heparan sulfate proteoglycans participate in hepatic lipase- and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 272:31285–31292.
Kang S-M, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738–743.
Khovidhunkit W, Farese RV Jr (1997) Resolution of propylthiouracil-induced hepatic failure after treatment of thyrotoxicosis. West. J. Med. 167:353–356.
Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG (1997) Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc. Natl. Acad. Sci. USA 94:6132–6137.
Kim JG, Keshava C, Murphy AA, Pitas RE, Parthasarathy S (1997) Fresh mouse peritoneal macrophages have low scavenger receptor activity. J. Lipid Res. 38:2207–2215.
Kostenis E, Conklin BR, Wess J (1997) Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant Gaq subunits. Biochemistry 36:1487–1495.
Kostenis E, Degtyarev MY, Conklin BR, Wess J (1997) The N-terminal extension of Gaq is critical for constraining the selectivity of receptor coupling. J. Biol. Chem. 272:19107–19110.
Kreuzer J, White AL, Knott TJ, Jien M-L, Mehrabian M, Scott J, Young SG, Haberland ME (1997) Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages. J. Lipid Res. 38:324–342.
Linton MF, Raabe M, Pierotti V, Young SG (1997) Reading-frame restoration by transcriptional slippage at long stretches of adenine residues in mammalian cells. J. Biol. Chem. 272:14127–14132.
Ludwig EH, Hopkins PN, Allen A, Wu LL, Williams RR, Anderson JL, Ward RH, Lalouel J-M, Innerarity TL (1997) Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J. Lipid Res. 38:1361–1373.
Mahley RW (1997) Apolipoprotein E: Structure and function in lipid metabolism and neurobiology. In: The Molecular and Genetic Basis of Neurological Disease, 2nd edition (Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds) Butterworth-Heinemann, Boston, pp 1037–1049.
Mahley RW (1997) The J. David Gladstone Institutes. Mol. Med. 3:569–571.
McCormick SPA, Allan CM, Taylor JM, Young SG (1997) The use of P1 bacteriophage clones to generate transgenic animals. In: Transgenic Animals: Generation and Use (Houdebine LM, ed) Harwood Academic Publishers, Amsterdam, pp 273–281.
McCormick SPA, Ng JK, Cham CM, Taylor S, Marcovina SM, Segrest JP, Hammer RE, Young SG (1997) Transgenic mice expressing human apoB95 and apoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein(a). J. Biol. Chem. 272:23616–23622.
McGeer PL, Walker DG, Pitas RE, Mahley RW, McGeer EG (1997) Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates b-amyloid protein activation of complement in vitro. Brain Res. 749:135–138.
Meiner V, Tam C, Gunn MD, Dong L-M, Weisgraber KH, Novak S, Myers HM, Erickson SK, Farese RV Jr (1997) Tissue expression studies on the mouse acyl-CoA:cholesterol acyltransferase gene (Acact): Findings supporting the existence of multiple cholesterol esterification enzymes in mice. J. Lipid Res. 38:1928–1933.
Mietus-Snyder M, Friera A, Glass CK, Pitas RE (1997) Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C. A role for oxidative stress. Arterioscler. Thromb. Vasc. Biol. 17:969–978.
Monteclaro FS, Arai H, Charo IF (1997) Molecular approaches to identifying ligand binding and signaling domains of C–C chemokine receptors. Methods Enzymol. 288:70–84.
Monteclaro FS, Charo IF (1997) The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand. J. Biol. Chem. 272:23186–23190.
Nielsen LB, McCormick SPA, Pierotti V, Tam C, Gunn MD, Shizuya H, Young SG (1997) Human apolipoprotein B transgenic mice generated with 207- and 145-kilobase pair bacterial artificial chromosomes. Evidence that a distant 5′-element confers appropriate transgene expression in the intestine. J. Biol. Chem. 272:29752–29758.
Pitas RE (1997) Cerebrospinal fluid lipoproteins, lipoprotein receptors, and neurite outgrowth. Nutr. Metab. Cardiovasc. Dis. 7:202–209.
Qian X, Balestra ME, Innerarity TL (1997) Two distinct TATA-less promoters direct tissue-specific expression of the rat apo-B editing catalytic polypeptide 1 gene. J. Biol. Chem. 272:18060–18070.
Sanan DA, Fan J, Bensadoun A, Taylor JM (1997) Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J. Lipid Res. 38:1002–1013.
Sanan DA, Newland DL (1997) Quantitating aortic atherosclerosis in rabbits and mice. Microsc. Microanal. 3 (Suppl 2):317–318.
Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF, Luster AD (1997) Murine monocyte chemoattractant protein (MCP)-5: A novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185:99–109.
Schecter AD, Rollins BJ, Zhang YJ, Charo IF, Fallon JT, Rossikhina M, Giesen PLA, Nemerson Y, Taubman MB (1997) Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J. Biol. Chem. 272:28568–28573.
Schneider DB, Dichek DA (1997) Intravascular stent endothelialization. A goal worth pursuing? Circulation 95:308–310.
Schulick AH, Vassalli G, Dunn PF, Dong G, Rade JJ, Zamarron C, Dichek DA (1997) Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J. Clin. Invest. 99:209–219.
Simmons T, Newhouse YM, Arnold KS, Innerarity TL, Weisgraber KH (1997) Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli. J. Biol. Chem. 272:25531–25536.
Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, Kabat D, Chesebro B, Goldsmith MA (1997) Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:7136–7139.
Taylor JM (1997) Transgenic rabbit models for the study of atherosclerosis. Ann. N.Y. Acad. Sci. 811:146–154.
Taylor JM, Fan J (1997) Transgenic rabbit models for the study of atherosclerosis. Front. Biosci. 2:298–308.
Vassalli G, Dichek DA (1997) Gene therapy for arterial thrombosis. Cardiovasc. Res. 35:459–469.
Véniant MM, Pierotti V, Newland D, Cham CM, Sanan DA, Walzem RL, Young SG (1997) Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J. Clin. Invest. 100:180–188.
Wong L-M, Myers SJ, Tsou C-L, Gosling J, Arai H, Charo IF (1997) Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J. Biol. Chem. 272:1038–1045.
Wu MJ, Chen-Liu LW, Xiao Q, Phillips ML, Elovson J, Linton MF, Young SG, Schumaker VN (1997) Secretion from cell culture of HDL and VLDL bearing apoB-33 with a large internal deletion. J. Lipid Res. 38:2473–2482.
Yamanaka S, Poksay KS, Arnold KS, Innerarity TL (1997) A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11:321–333.
TOP
